Cardiovascular Diabetology appointed Dr. Pasquale Paolisso as Social Media Editor!
He will be selecting Cardiovascular Diabetology articles to be promoted on X each week based on highest quality of content and graphical abstract. Authors who want to promote their article in X are encouraged to tag Dr. Paolisso (@P_Paolisso) in their tweets.
Aims and scope
Cardiovascular Diabetology considers manuscripts on all aspects of the diabetes/cardiovascular interrelationship and the metabolic syndrome; this includes clinical, genetic, experimental, pharmacological, epidemiological and molecular biology research.
Call for Papers: Perivascular adipose tissue: friend or foe in cardiometabolic disorders
Edited by:
Dr. Cristina Sena, PhD, University of Coimbra, Portugal
Submission Status: Open until 31 January 2025
Call for Papers: Cardiometabolic HFpEF with focus on type 2 diabetes mellitus
Edited by:
Professor Francesco Paneni, MD, PhD, Department of Cardiology and CTEC, University Hospital and University of Zürich, Switzerland
Dr. Era Gorica, PhD, Department of Cardiology and CTEC, University Hospital and University of Zürich, Switzerland
Submission Status: Open until 20 November 2024
Articles
-
-
Cardiometabolic benefits of fenofibrate in heart failure related to obesity and diabetes
-
Sex inequalities in cardiovascular risk factors and their management in primary prevention in adults living with type 1 diabetes in Germany and France: findings from DPV and SFDT1
-
Effects of dietary interventions and intermittent fasting on HDL function in obese individuals with T2DM: a randomized controlled trial
-
Identification of potential therapeutic targets for nonischemic cardiomyopathy in European ancestry: an integrated multiomics analysis
-
Comparison of vildagliptin twice daily vs. sitagliptin once daily using continuous glucose monitoring (CGM): Crossover pilot study (J-VICTORIA study)
-
How hyperglycemia promotes atherosclerosis: molecular mechanisms
-
Association between insulin resistance and the development of cardiovascular disease
-
Beneficial effects of a Paleolithic diet on cardiovascular risk factors in type 2 diabetes: a randomized cross-over pilot study
-
Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin
Cardiovascular Diabetology strongly encourages authors to submit a graphical abstract along with their manuscript.
Articles with graphical abstracts will be prioritized for social media promotion.
2023 Editor's highlights
Click here for a selection of 2023 highlight articles published in Cardiovascular Diabetology.
From the blog
Announcing the launch of In Review
Cardiovascular Diabetology, in partnership with Research Square, is now offering In Review. Authors choosing this free optional service will be able to:
- Share their work with fellow researchers to read, comment on, and cite even before publication
- Showcase their work to funders and others with a citable DOI while it is still under review
- Track their manuscript - including seeing when reviewers are invited, and when reports are received
Editors' quotes
"Since the American Heart Association stated in 1999 that "diabetes is a cardiovascular disease", many revolutionary events took place in the rapidly evolving field of cardiovascular diabetology. The initial 'bridal' between heart diseases and diabetes is at present a vast and complex interdisciplinary texture which includes innovative biotechnological approaches, such as genomics, proteomics, metabolomics, molecular biometrics, bioinformatics, customized therapies and various additional sophisticated practices. Our journal endeavors to be a harbinger of these fascinating advances."
Professor Enrique Fisman, Editor-in-Chief, Cardiovascular Diabetology
"A strong correlation between cardiovascular disease and diabetes is now well established. The American Heart Association considers that individuals with insulin resistance or diabetes are more likely to fall victim to heart disease or stroke. Cardiovascular Diabetology is the world's foremost journal specifically devoted to this issue. Submitted manuscripts may report any aspect of laboratory, animal, or human research related to diabetes and its cardiovascular complications"
Professor Alexander Tenenbaum, Editor-in-Chief (2002-2021), Cardiovascular Diabetology
Cardiovascular Diabetology is affiliated with Sackler Faculty of Medicine, Tel-Aviv University
Annual Journal Metrics
-
Citation Impact 2023
Journal Impact Factor: 8.5
5-year Journal Impact Factor: 8.9
Source Normalized Impact per Paper (SNIP): 1.855
SCImago Journal Rank (SJR): 2.621Speed 2023
Submission to first editorial decision (median days): 2
Submission to acceptance (median days): 56Usage 2023
Downloads: 2,523,778
Altmetric mentions: 3,115